Ashlea Broomfield chats with clinical pharmacist Geraldine Moses about the potential adverse effects from some commonly used vitamins and minerals, especially when taken in high doses.

Justin Coleman chats to hepatologist Alex Thompson about livers and what can go wrong with them, including hepatitis B, C and non-alcoholic fatty liver disease.

David Liew talks to Rob Moulds about the challenges facing rational prescribing and quality use of medicines in Australia today.

Jo Cheah talks to sleep physician David Cunnington about how GPs and other primary health providers can help patients struggling with lack of sleep.

Dhineli Perera chats with ophthalmologist Hemal Mehta about how commonly prescribed oral drugs can have adverse effects on the eye. What are the symptoms, and the drugs, you should watch out for?

Managing pain involves more than just analgesia, as reflected in the Therapeutic Guidelines’ extensive revision of this topic. Justin Coleman chats to pain specialist Chris Hayes about the more holistic, multidimensional approach to pain management.

Over 40% of people who have a stroke have another one within 10 years. Dhineli Perera chats to clinical pharmacologist Chris Tremonti about the drugs used to lower the risk of a secondary ischaemic stroke or TIA.

Jo Cheah chats to Katie Frith about the latest updates to the anaphylaxis guidelines, and what this means for infants and children and positioning of the patient.

Ashlea Broomfield chats to Varan Perananthan about prescribing opioids and antidepressants, and which combinations to avoid.

David Liew chats with infectious diseases physician Dr Gregory Dore about the strategies required to achieve elimination of hepatitis C in Australia by 2030.